Literature DB >> 16872803

Effect of deep brain stimulation on different speech subsystems in patients with multiple sclerosis.

Manfred Pützer1, William John Barry, Jean Richard Moringlane.   

Abstract

The effect of deep brain stimulation on articulation and phonation subsystems in seven patients with multiple sclerosis (MS) was examined. Production parameters in fast syllable-repetitions were defined and measured, and the phonation quality during vowel productions was analyzed. Speech material was recorded for patients (with and without stimulation) and for a group of healthy control speakers. With stimulation, the precision of glottal and supraglottal articulatory gestures is reduced, whereas phonation has a greater tendency to be hyperfunctional in comparison with the healthy control data. Different effects on the two speech subsystems are induced by electrical stimulation of the thalamus in patients with MS.

Entities:  

Mesh:

Year:  2006        PMID: 16872803     DOI: 10.1016/j.jvoice.2006.05.007

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  4 in total

Review 1.  [Functional MRI of speech].

Authors:  C M Krick; M Backens; M Pützer; W Reith
Journal:  Radiologe       Date:  2013-07       Impact factor: 0.635

Review 2.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

3.  Measures to Evaluate the Effects of DBS on Speech Production.

Authors:  Gary Weismer; Yana Yunusova; Kate Bunton
Journal:  J Neurolinguistics       Date:  2012-03       Impact factor: 1.710

4.  The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study.

Authors:  Doris Mücke; Anne Hermes; Timo B Roettger; Johannes Becker; Henrik Niemann; Till A Dembek; Lars Timmermann; Veerle Visser-Vandewalle; Gereon R Fink; Martine Grice; Michael T Barbe
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.